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ABSTRACT
Stroke is a frequent complication in patients with cancer occurring in nearly 15% of the cases. However 
cerebrovascular disease as the first presentation of malignancy has rarely been reported.
We report two such cases who were admitted with acute stroke but were later on found to be having malignancy. 
Routine workup was unrewarding in both patients. Both patients developed pulmonary embolism as well during 
hospital stay suggesting hypercoagulable state as likely etiology. Reaching to the final diagnosis was an arduous 
journey but can help guide other clinicians facing similar cases. Non Hodgkins B cell lymphoma and Carcinoma Gall 
bladder were the final diagnosis in our patients. Therefore, we recommend workup for malignancy if no likely cause is 
found on routine extensive workup before labelling stroke as cryptogenic stroke. Ultrasound abdomen was particularly 
rewarding in our patients.
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INTRODUCTION
Stroke is a frequent complication in patients with 
cancer occurring in nearly 15% of the cases. However 
cerebrovascular disease as the first presentation of 
malignancy has rarely been reported1.
We hereby report two of such cases where final 
diagnosis was actually a malignancy but presented with 
acute stroke and where we did routine extensive 
workup for the etiology of stroke but was unrewarding.
CASE 1
83 years old female was admitted with history of left 
sided visual field loss. She had risk factors of stroke in 
form of hypertension, hypercholestrolaemia. She also 
had Polymyalgia rheumatica and was on steroids. 
On examination she was conscious alert with normal 
vital signs. Neurological examination was all normal 
except for right homonymous hamianopia.
Her investigations showed anaemia with Haemoglobin 
of 8 with MCV 68. Her ESR was raised to 124 and CRP 
was 259.8. Her CT brain scan confirmed a left occipital
infarct as shown in Figure 1.
Figure 1.CTscan brain showing left occipital infarct.
Her anaemia was investigated. Her OGD was normal. 
Her colonoscopy revealed angiodysplasia of colon, 
argon plasma coagulation was done on caecum.
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Her echocardiogram showed mild pulmonary 
hypertension and moderate to severe Aortic stenosis.
Her liver function tests showed deranged ALT of 181 
which was initially attributed to Statins use. An 
ultrasound abdomen was done which showed 
heterogenous Hypoechoic round lesion at splenic hilum 
measuring 2.5cm. It was the deranged LFTs which led 
us to do ultrasound abdomen and led us to underlying 
diagnosis.
She kept on spiking high grade intermittent fever for 
which all relevant investigations were done including 
septic screen, blood cultures which showed no growth, 
serum immunoglobulins, serum electrophoresis, serum 
autoantibodies and serum complement levels which 
were normal.
CT abdomen showed solid mass in spleen with 
extensive lymphedenopathy in the upper abdomen and 
Lymphoma was suspected.
She also developed shortness of breath and hypoxia 
during hospital stay, CTPA was done and showed 
Segmental Pulmonary embolus within a branch of right 
upper lobe artery.
She was started on therapeutic dose of Dalteparin CT 
guided lymph node biopsy confirmed High grade B cell 
Lymphoma.
CASE 2
A 62 years old lady with no previous comorbids except 
for DVT leg for which she was on Rivaroxaban presented 
to us with left arm weakness and facial droop was 
diagnosed as having right lacunar stroke. After few 
months she was readmitted with multiple episodes of 
aphasia, one episode rendering her completely aphasic.
MRI brain confirmed new stroke and showed areas of 
restricted diffusion bilateraly in both anterior circulations 
and posterior circulation as shown in figure 2.
Figure 2.MRI brain DWI sequence showing bilateral 
infarcts.
All the workup for recurrent stroke including 
Anticardiolipin antibodies IgG and IgM, Thrombophilia 
and vasculitic screen was negative.24 hours and 5 days 
ECG monitoring was normal. Transthoracic 
Echocardiogram was normal. Bubble contrast 
echocardiogram showed PFO.
Ultrasound abdomen was done during the course of 
hospital stay which showed a mass lesion involving the 
fundus of the gallbladder and the adjacent liver. It also 
showed small hypoechoic lesions in the adjacent liver. 
Carcinoma of the gallbladder with metastases was 
suspected. 
CT abdomen and pelvis confirmed large mass of mixed 
density in the gallbladder fossa with a thick enhancing 
rim and another 2 cm well-defined low density lesion in 
the liver.. Possibility was of gallbladder malignancy, liver 
lesion was suspicious for a metastatic deposit.
She was Started on Therapeutic Dose Dalteparin. PEG 
tube inserted
While on Dalteparin therapeutic dose developed 
extensive left femoral vein DVT extending into left illiac 
vein upto illiac bifurcation. IVC filter was placed.
She also developed acute shortness of breath during 
hospital stay, CTPA confirmed Pulmonary embolism in 
form of segmental pulmonary emboli within right lower 
lobe and Lingula and left lower lobe.
Gall bladder biopsy was taken and GB malignancy 
proven. She was referred to acute Oncology and 
Palliative care.
DISCUSSION
Both the patients were interesting because of the fact 
that they first presented with stroke and were later on 
found to be having a malignancy. Stroke as a first 
presentation of malignancy is a rare phenomenon1. 
There are many ways in which stroke occurs in cancer 
as mentioned in different studies. Coagulopathic 
conditions involve disseminated intravascular 
coagulation, thrombocytopenia, nonbacterial 
thrombotic endocarditis, and cerebral intravascular 
coagulation2.
Complications of chemotherapy, radiation therapy, 
direct tumor effects include intratumoral hemorrhage, 
arterial and venous sinus invasion by tumor mass or 
leptomeningeal infiltrates, and tumor emboli, all can 
occur2.
Finally, septic infarction from fungal or bacterial sepsis 
and infectious vasculitis can manifest in cancer 
patients immunocompromised by malignancy or cancer 
therapy2.
In many cases a combination of mechanisms is 
causative, and both hemorrhagic and ischemic stroke 
can occur2. 
Cancer-associated hyper- coagulation as a relevant 
stroke etiology was confirmed in many studies3,4. In a 
study it was found that patients with elevated d-dimer 
levels in the absence of other conventional stroke 
etiologies and/or infarction in multiple vascular 
territories or small embolic infarction are the ones with 
increased risk for stroke3. Same study also suggested 
that patients presenting with lung or pancreatic cancer 
as well as patients with metastatic disease are at 
highest risk for cancer-associated stroke3. They also 
proposed that diagnostic workup should include a 
broad laboratory assessment of hypercoagulability 
including d-dimer levels in all patients with 
cancer+stroke3.
It was interesting to note here that our both patients 
developed pulmonary embolism as well. It has been 
suggested in few studies that patients with suspected 
cancer-associated hypercoagulability should also be 
screened for other thromboembolic complications 
especially deep vein thrombosis which it is of 
therapeutic significance4.Our second patient had a DVT 
prior to having stroke. Also interesting was to note was 
the fact that our second patient developed first stroke 
while she was on oral anticoagulant Rivaroxaban and 
again developed extensive DVT of leg while on 
therapeutic doses of Dalteparin(LMVH) suggesting a 
severe hypercoagulable state.
Therefore, we suggest that in patients with stroke in 
which the usual workup is negative, before labelling 
them as cryptogenic stroke, workup/ screening for 
hidden malignancy should be undertaken. This holds 
particularly true if if there is suspicion of hypercoaguble 
state, especially if D dimers are very high, if there is 
evidence of DVT/PE, stroke has affected multiple 
arterial territories, thrombophilia screen is negative and 
there is evidence of anaemia and inflammatory markers 
are raised. Ultrasound abdomen was particularly 
rewarding in this regard. Our both patients were 
diagnosed on ultrasound abdomen.
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